Cargando…
lncRNA ROR Promotes Gastric Cancer Drug Resistance
OBJECTIVE: Gastric cancer is one of the most common malignant tumors worldwide, and for resectable tumors, the most effective treatment is surgery with chemotherapy in neoadjuvant or adjuvant setting. However, the majority of patients fail to achieve the ideal initial response and/or develop resista...
Autores principales: | Wang, Shuai, Chen, Wujun, Yu, Hualong, Song, Zhengming, Li, Qian, Shen, Xin, Wu, Yudong, Zhu, Lei, Ma, Qingxia, Xing, Dongming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7003177/ https://www.ncbi.nlm.nih.gov/pubmed/32019330 http://dx.doi.org/10.1177/1073274820904694 |
Ejemplares similares
-
LncRNA DANCR promotes migration and invasion through suppression of lncRNA-LET in gastric cancer cells
por: Mao, Zhengqiang, et al.
Publicado: (2017) -
lncRNA ROR promotes the progression of renal cell carcinoma through the miR-206/VEGF axis
por: Shi, Jianguo, et al.
Publicado: (2019) -
Prognostic value of lncRNA ROR expression in various cancers: a meta-analysis
por: Lu, Renfu, et al.
Publicado: (2018) -
lncRNA 430945 promotes the proliferation and migration of vascular smooth muscle cells via the ROR2/RhoA signaling pathway in atherosclerosis
por: Cui, Chuan, et al.
Publicado: (2019) -
LncRNA ROR1-AS1 high expression and its prognostic significance in liver cancer
por: Zhang, Ze, et al.
Publicado: (2020)